Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Avadel Pharmaceuticals (Nasdaq: AVDL) announced on October 13, 2025 that its Compensation Committee approved inducement option awards for seven new employees totaling 161,600 ordinary shares under the company's 2021 Inducement Plan.
The non-statutory options carry a 10-year term and vest over four years with 25% vesting after one year and 25% on each of the second, third, and fourth anniversaries of each employee's start date. Awards are granted as inducements under Nasdaq Listing Rule 5635(c)(4) and are subject to the 2021 Inducement Plan and individual award agreements.
Avadel Pharmaceuticals (Nasdaq: AVDL) ha annunciato il 13 ottobre 2025 che il suo Compensation Committee ha approvato premi di opzione di incentivazione per sette nuovi dipendenti per un totale di 161.600 azioni ordinarie ai sensi del piano di incentivazione 2021 dell'azienda.
Le opzioni non statutarie hanno una durata di 10 anni e maturano in quattro anni con il 25% maturato dopo un anno e il 25% al secondo, terzo e quarto anniversario della data di inizio di ciascun dipendente. I premi sono concessi come incentivi ai sensi della Nasdaq Listing Rule 5635(c)(4) e sono soggetti al Piano di Incentivazione 2021 e agli accordi individuali di assegnazione.
Avadel Pharmaceuticals (Nasdaq: AVDL) anunció el 13 de octubre de 2025 que su Comité de Compensación aprobó premios de opción de incentivo para siete nuevos empleados por un total de 161.600 acciones ordinarias conforme al Plan de Incentivo 2021 de la empresa.
Las opciones no estatutarias tienen un plazo de 10 años y se consolidan (o vencen) en cuatro años, con un 25% de vesting después de un año y un 25% en cada uno de los segundos, terceros y cuartos aniversarios de la fecha de inicio de cada empleado. Los premios se otorgan como incentivos conforme a la Regla de Listado Nasdaq 5635(c)(4) y están sujetos al Plan de Incentivo 2021 y a los acuerdos de adjudicación individual.
Avadel Pharmaceuticals (Nasdaq: AVDL)가 2025년 10월 13일에 보상위원회가 해당 회사의 2021년 Inducement Plan에 따라 7명의 신규 직원에게 총 161,600주 보통주의 유도형 옵션 보상을 승인했다고 발표했습니다.
비법정 옵션은 10년의 기간을 가지며 4년에 걸쳐 vesting 되며 시작일로부터 1년 후 25%, 두 번째, 세 번째, 네 번째 해의 각 기념일에 25%씩 vesting됩니다. 보상은 Nasdaq Listing Rule 5635(c)(4)에 따른 유도책으로 부여되며 2021 Inducement Plan 및 개별 수여 계약의 적용을 받습니다.
Avadel Pharmaceuticals (Nasdaq : AVDL) a annoncé le 13 octobre 2025 que son Comité de rémunération a approuvé des attributions d’options d’induction pour sept nouveaux employés, pour un total de 161 600 actions ordinaires, dans le cadre du Plan d’Induction 2021 de la société.
Les options non statutaires ont une durée de 10 ans et s’acquièrent sur quatre ans avec 25% qui s’acquièrent après un an et 25% lors du deuxième, troisième et quatrième anniversaires de la date de début de chaque employé. Les attributions sont accordées à titre d’inducements conformément à la Nasdaq Listing Rule 5635(c)(4) et sont soumises au Plan d’Induction 2021 et aux accords d’attribution individuels.
Avadel Pharmaceuticals (Nasdaq: AVDL) gab am 13. Oktober 2025 bekannt, dass der Vergütungsausschuss Inducement-Optionen für sieben neue Mitarbeiter im Gesamtumfang von 161.600 Stammaktien gemäß dem unternehmensweiten Inducement Plan 2021 genehmigt hat.
Die nicht-statutorischen Optionen haben eine Laufzeit von 10 Jahren und vesten über 4 Jahre, wobei 25% nach einem Jahr und 25% an den zweiten, dritten und vierten Jahrestagen des Arbeitsbeginns jedes Mitarbeiters vesten. Die Zuwendungen werden als Inducements gemäß Nasdaq Listing Rule 5635(c)(4) gewährt und unterliegen dem Inducement Plan 2021 sowie individuellen Zuweisungsvereinbarungen.
Avadel Pharmaceuticals (ناسداك: AVDL) أعلنت في 13 أكتوبر 2025 أن لجنة التعويض وافقت على منح خيارات تحفيزية لسبعة موظفين جدد بإجمالي 161,600 سهم عادي وفقاً لخطة الحث 2021 للشركة.
الخيارات غير النظامية لها مدة 10 سنوات وتكتسب خلال أربع سنوات مع استحقاق 25% بعد مرور عام و25% في كل من ذكرى السنة الثانية والثالثة والرابعة لبداية عمل كل موظف. تُمنح الجوائز كمحفِّزات بموجب قاعدة إدراج ناسداك 5635(c)(4) وتخضع لخطة الحث 2021 وللأحكام الخاصة بكل من منح الاتفاقيات الفردية.
Avadel Pharmaceuticals（纳斯达克：AVDL） 于 2025年10月13日 宣布，其薪酬委员会已批准基于公司 2021 年诱导计划 对七名新员工授予总计 161,600 股普通股 的诱导性期权。
这些非法定期权的期限为 10 年，在 四年 内分阶段归属，起始日起一年后归属 25%，其后在第二、第三和第四个周年日各归属 25%。该等奖励作为诱导授予，依据 纳斯达克上市规则 5635(c)(4) 进行，并受 2021 年诱导计划 与个人授予协议的约束。
- None.
- None.
DUBLIN, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to seven (7) new employees to purchase 161,600 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employee’s acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years and older with narcolepsy. For more information, please visit www.avadel.com.
Investor Contact:
Austin Murtagh
Precision AQ
Austin.Murtagh@precisionAQ.com
(212) 698-8696
Media Contact:
Alyssa Ramirez
Real Chemistry
aramirez@realchemistry.com
FAQ
What did Avadel (AVDL) announce on October 13, 2025 regarding employee stock options?
How long is the term for Avadel's inducement options (AVDL) granted October 13, 2025?
What is the vesting schedule for Avadel (AVDL) inducement awards dated October 13, 2025?
Under which Nasdaq rule were Avadel's (AVDL) inducement awards approved?
How many employees received inducement option grants from Avadel (AVDL) on October 13, 2025?
Are Avadel's (AVDL) inducement options subject to plan terms and individual agreements?
